Prader-Willi Syndrome (PWS) Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Prader-Willi Syndrome (PWS) Market is segmented By Growth Hormone Therapy (GENOTROPIN, NORDITROPIN, OMNITROPE), By Hyperphagia Treatment (DCCR, Carbetocin, ARD-101), By Behavioral and Sleep Management (WAKIX), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
Prader-Willi Syndrome (PWS) Market Size
Market Size in USD
CAGR7%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 7% |
| Market Concentration | High |
| Major Players | Soleno Therapeutics, Harmony Biosciences, Pfizer, Novo Nordisk, Sandoz |
please let us know !
Prader-Willi Syndrome (PWS) Market Analysis
The Prader-Willi Syndrome (PWS) market is estimated to be valued at USD 0.916 Bn in 2024 and is expected to reach USD 1.47 Bn by 2031, growing at a compound annual growth rate (CAGR) of 7% from 2024 to 2031.
Increase in research funding for developing new and improved treatment options for PWS is a key factor driving the market. Several clinical trials evaluating the safety, efficacy of new treatment approaches such as restriction of calorie intake, growth hormone supplementation, and behavior therapy are currently underway.